Sun Pharmaceutical Industries Limited
SUNPHARMA
Κατάταξη σε μετοχές
#527
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Τιμή μετοχής
$19.24
Κεφαλαιοποίηση
$46.15B
Αλλαγή (1 ημέρα)
-0.97%
Αλλαγή (1 έτος)
0.84%
Χώρα
IN
Εμπόριο Sun Pharmaceutical Industries Limited (SUNPHARMA)
Κατηγορία
Healthcare
EPS για Sun Pharmaceutical Industries Limited (SUNPHARMA)
EPS στις June 2026 TTM: $0.56
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Sun Pharmaceutical Industries Limited, το τρέχον EPS της εταιρείας (TTM) είναι $0.56. Στο τέλος του 2024, η εταιρεία είχε EPS $0.48, αύξηση σε σχέση με το EPS του 2023 που ήταν $0.43.
Ιστορικό EPS της Sun Pharmaceutical Industries Limited από 2004 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.56 | 4.96% |
| 2025 | $0.53 | 11.41% |
| 2024 | $0.48 | 11.35% |
| 2023 | $0.43 | 139.18% |
| 2022 | $0.18 | 8.71% |
| 2021 | $0.17 | -20.64% |
| 2020 | $0.21 | 30.19% |
| 2019 | $0.16 | 15.61% |
| 2018 | $0.14 | -69.05% |
| 2017 | $0.45 | 56.75% |
| 2016 | $0.29 | -5.81% |
| 2015 | $0.30 | 19.44% |
| 2014 | $0.25 | -4.30% |
| 2013 | $0.27 | 4.58% |
| 2012 | $0.25 | 29.09% |
| 2011 | $0.20 | 35.66% |
| 2010 | $0.14 | -16.31% |
| 2009 | $0.17 | -7.39% |
| 2008 | $0.19 | 94.07% |
| 2007 | $0.10 | 38.62% |
| 2006 | $0.07 | 41.63% |
| 2005 | $0.05 | 19.51% |
| 2004 | $0.04 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CH
|
